|Up a level|
Arimappamagan, Arivazhagan and Somasundaram, Kumaravel and Thennarasu, Kandavel and Peddagangannagari, Sreekanthreddy and Srinivasan, Harish and Shailaja, Bangalore C and Samuel, Cini and Patric, Irene Rosita Pia and Shukla, Sudhanshu and Thota, Balaram and Prasanna, Krishnarao Venkatesh and Pandey, Paritosh and Balasubramaniam, Anandh and Santosh, Vani and Chandramouli, Bangalore Ashwathnarayanara and Hegde, Alangar Sathyaranjandas and Kondaiah, Paturu and Rao, Sathyanarayana Manchanahalli R (2013) Fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group. In: PLOS One, 8 (4). e62042_1-e62042_14.
Thota, Balaram and Shukla, Sudhanshu K and Srividya, Mallavarapu R and Shwetha, Shivayogi D and Arivazhagan, Arimappamagan and Thennarasu, Kandavel and Chickabasaviah, Yasha T and Hegde, Alangar S and Chandramouli, Bangalore A and Somasundaram, Kumarvel and Santosh, Vani (2012) IDH1 Mutations in Diffusely Infiltrating Astrocytomas Grade Specificity, Association With Protein Expression, and Clinical Relevance. In: AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 138 (2). pp. 177-184.
Suvasini, Ramaswamy and Shruti, Bhargava and Thota, Balaram and Shinde, Sridevi Vijay and Friedmann-Morvinski, Dinorah and Nawaz, Zahid and Prasanna, Krishnarao Venkatesh and Thennarasu, Kandavel and Hegde, Alangar Sathyaranjandas and Arivazhagan, Arimappamagan and Chandramouli, Bangalore Ashwathnarayanarao and Santosh, Vani and Somasundaram, Kumaravel (2011) Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2. In: Journal of Biological Chemistry, 286 (29). pp. 25882-25890.